Related Experiment Videos
Can drugs or micronutrients prevent cataract?
1Nuffield Laboratory of Ophthalmology, University of Oxford, England. john.harding@eye.ox.ac.uk
Drugs & Aging
|August 3, 2001
Summary
Preventing cataracts, a leading cause of blindness, remains a challenge. Current research on drugs and micronutrients shows limited success, with no licensed therapies available.
Area of Science:
- Ophthalmology
- Pharmacology
- Nutritional Science
Background:
- Cataract is a primary cause of global blindness and visual impairment.
- Current treatment relies solely on surgery, which is costly and carries risks.
- No pharmaceutical interventions are currently licensed for cataract prevention in major markets.
Purpose of the Study:
- To review research on various agents for cataract prevention.
- To focus on extensively studied compounds and their efficacy.
- To evaluate evidence from laboratory and epidemiological studies.
Main Methods:
- Review of in vitro and in vivo laboratory experiments.
- Analysis of epidemiological studies in patient populations.
- Examination of clinical trial data for anticataract agents.
Main Results:
- Sorbitol-lowering drugs showed disappointing clinical trial results.
- Micronutrients demonstrated limited promise in animal models and human trials.
- Pantethine trials were inconclusive, with one abandoned early.
- Aspirin-like drugs have supporting evidence but lack specific cataract trials.
Conclusions:
- No consistently effective drug therapy for cataract prevention has been identified.
- Further research is needed to explore promising compounds.
- The development of effective, non-surgical cataract prevention strategies remains a priority.